A monoclonal antibody (MAb), N2, neutralized human cytomegalovirus (HCMV) infectivity in the absence of complement and recognized a normal cell protein. By immunofluorescence, MAb N2 detected antigens in uninfected human cells, but not in cells of non-human origin. Antigens were present at the membrane and were dispersed diffusely within the cytoplasm. MAb N2 immunoprecipitated a glycoprotein with an M r of 94K from uninfected and infected cells. In infected cells only, it also recognized a protein of Mr 34K which was not linked to the 94K Mr glycoprotein by disulphide bonds. N2 neutralized both laboratory and field isolates of HCMV. A study of the distribution of the N2 neutralization epitope recognized among fresh isolates of HCMV showed that only 67~ of the isolates could be neutralized by this antibody. There was no correlation between the number of in vitro passages and the level of neutralization. The 34K Mr polypeptide was present in cells infected by all isolates. It thus appears that, during virus assembly, HCMV acquires a normal cell protein that bears a neutralization epitope.
INTRODUCTION
Several pathogenetic and immunological aspects of cytomegalovirus (CMV) infection remain perplexing. Acute CMV infection is associated with renal graft rejection (reviewed in Betts, 1984) and the development of graft-versus-host disease in bone marrow transplants (L6nnqvist et al., 1984) . Humoral immunity to human CMV (HCMV) appears to be more effective as an indicator of past encounter with this agent than as a protective factor from infection or viral reactivation. Virus is transmitted from mother to child in the face of high antibody titres (reviewed in Stagno et al., 1984) . Immunosuppressed individuals who succumb to HCMV disease most often have high titres of circulating antibodies. These observations raise questions concerning the interaction of HCMV-specific antibodies with virus structural and nonstructural proteins and the effect of such interactions on controlling, or otherwise affecting, the course of HCMV infection. Fujinami et al. (1987) recently showed sequence homology and immunological cross-reactivity between an immediate early region 2-coded protein and HLA-DR/~ molecules. More recently, Beck & Barrell (1987) have shown by DNA sequence analysis that the HCMV AD169 strain HindlII 0 fragment bears a gene which potentially encodes a glycoprotein homologous to HLA class I antigens. Cellular DNA-related sequences have been reported within the CMV genome (Riiger et al., 1984; Shaw et al., 1985; Staprans & Spector, 1986) . The function of these genes in the replicative cycle and the importance of their products in anti-HCMV immunological reactions remain to be discovered.
In the light of these observations and questions, we were interested to find a murine monoclonal antibody (MAb) that neutralized HCMV infectivity and recognized a normal cell 0000-8398 © 1989 SGM s. MICHELSON AND OTHERS protein. The distribution of the epitope recognized was studied on uninfected cells and cells infected with laboratory strains and fresh isolates of HCMV. The presence of the antigenic determinant as part of a functional neutralization epitope was variable among flesh viral isolates and was not related to the number of in vitro passages.
METHODS

Cells and viruses.
The AD169 and Davis strains of HCMV were purchased from the American Type Culture Collection. Towne strain was a gift from Dr M. F. Stinski (University of Iowa, Iowa City, Iowa, U.S.A.). All were grown in MRC-5 cells (Jacobs et al., 1970) in Dulbecco's medium containing 20 mM-Tricine and 0-11 ~ sodium bicarbonate (growth medium) supplemented with 10~ calf serum (Veterinary Medical Supplies). An antibiotic (50 ktg/ml gentamicin) was used only when plates were used. Details concerning the fresh isolates used here have been published elsewhere (Colimon et al., 1985) . Cell and virus stocks were routinely found to be negative for mycoplasma.
MAbs. Mice were immunized with AD169 strain HCMV-infected cells. Hybridomas were screened by seroneutralization. ELISA, haemagglutination and immunofluorescence. The details of cell fusion, hybridoma screening and cloning have been described previously (Amad~i et at., 1983) . On subcloning of hybridoma 'N' by limiting dilution, 11 out of 96 wells yielded clones, six of which secreted neutralizing antibodies and one of which did not. The MAb used here was described earlier (Amad~i et al., 1983) as N2. IgGs were purified from a pool of anti-poliovirus MAbs (generously provided by Dr R. Crainic, Institut Pasteur) and the same pool was used as control antibody throughout these experiments. The subclasses of purified IgGs were determined by Drs S. Avrameus and T. Ternynck (Institut Pasteur) by ELISA. N2 IgG was IgG2b. The anti-poliovirus pool contained 31~ IgG1, 51~ IgG2a, 14~ IgG2b and 3~ IgG3.
Purification ofimmunoglobulins. MAb N2 ascites or a pool of anti-poliovirus MAbs ascites was diluted 1/5 with glycine buffer (0.1 t,i-glycine pH 8.9, 3 M-NaCI). Immunoglobulins were purified by adsorption to Protein ASepharose (Pharmacia) at a ratio of 1 ml of undiluted ascites/2 ml of swollen gel equilibrated in glycine buffer. After washing, the column was eluted with 0.1 M-sodium citrate buffer pH 3. Peak fractions were pooled and the protein content estimated by spectrophotometry at 280 nm. IgG-containing fractions were then neutralized by addition of 1 M-NaOH, dialysed against phosphate-buffered saline (PBS) and stored in 50~ glycerol at -30 °C.
Membrane immunofluorescence. Fluorescence was performed by incubating unfixed cells with N2 or antipoliovirus ascites diluted 1/100 in PBS containing Ca z+ and Mg 2+ for 30 rain at 37 °C. After washing, cells were incubated with a 1/80 dilution of fluorescein isothiocyanate-conjugated anti-mouse IgG (heavy and light chains, |nstitut Pasteur) for 30 rain at 37 °C. Cells were examined and photographed using a Leitz Dialux fluorescence microscope and Ilford HP-5 film developed at 600 ASA.
Neutralization tests. The neutralization test has been described previously (Amad6i et al., 1983) . Control wells received irrelevant anti-poliovirus antibody and were incubated in parallel. Complement was not used in the tests. All samples were run in triplicate in each experiment and all experiments were performed at least twice. MAbs were considered neutralizing if they reduced infectivity by more than 50~o. The neutralization titre of N2 ascites fluid with the prototype AD169 strain of HCMV was 1/800 to 1/1600. Neutralization of fresh isolates was performed by titrating extracellular virus in the presence and absence of a 1/100 dilution of N2 ascites fluid. Prototype strains AD169 and Davis were neutralized in parallel.
Radiolabelling of cells and preparation of antigens. At 75 ~ confluence, uninfected MRC-5 monolayers were labelled for 24 h by replacing medium with a mixture (3 : 1) of growth medium and methionine-free Eagle's MEM containing 1 ~ calf serum and [35S]methionine (sp. act. >/1300 Ci/mmol; Amersham) at a final concentration of 10 ~tCi/ml. At the end of the labelling period, cells were chased for 4 h in growth medium supplemented with unlabelled methionine and 10~ calf serum. Cells were then infected with > 1 p.f.u./cell of the Davis strain by adsorption of virus for 2 h at 37 °C. Cells were sampled immediately after the 4 h chase and at different times after infection. Davis strain-infected cells were also labelled for 24 h from 72 to 96 h after infection using the same labelling medium. For labelling of glycoproteins, uninfected cells and cells infected for 72 h were incubated in glucose-free medium containing 15 ktCi/ml of [14C]glucosamine (sp. act. 277 mCi/mmol; Amersham) for 18 h. Parallel cultures were labelled with [35S]methionine.
For short pulse-chase experiments, 4 days after infection cells were deprived of methionine by incubating for I0 min in methionine-free MEM without serum. They were then pulse-labelled for 10 rain in the same medium containing 20 IxCi/ml of [35S]methionine. After the pulse, cells were washed twice with Dulbecco's medium containing 10~ calf serum, then incubated in the same medium during the chase periods.
For the preparation of antigens using fresh HCMV isolates, cells were inoculated by transfer of infected cells onto uninfected MRC-5 monolayers. When the c.p.e, involved > 90~ of the monolayer, antigens were extracted.
Cell extracts were prepared as follows. Monolayers were washed twice in situ with cold PBS containing Ca 2+ and Mg 2+ ions. Ceils were scraped into the same buffer, centrifuged and resuspended in extraction buffer [50 mM-Tris-HC1 pH 7.4, 2 mM-EDTA, 1 mM-2-mercaptoethanol, 1 ~ Nonidet P40 (a gift from Shell), 1 ~ sodium deoxycholate Immunoprecipitation and PAGE analysis. Cell extracts were incubated at a ratio of 1 mg of protein/10 ~tg of purified IgG for 1.5 h at room temperature with shaking. Antigen-antibody complexes (Ag-Ab) were captured with Protein A in the form of heat-and formaldehyde-inactivated Staphylococcus aureus (SA), generously grown for us by Drs T. Horaud and G. Beith (Institut Pasteur) according to Kessler (1975) . A 10% suspension of bacteria in extraction buffer (see above) was added in a ratio of 10 p.l SA/ktg IgG and incubation was continued for 15 min at room temperature. All preparations were precipitated in parallel with the same amount of the same pool of irrelevant purified anti-poliovirus IgG (generous gift of R. Crainic, Institut Pasteur). Ag-Ab-SA complexes were washed three times in extraction buffer (see above) then dissociated in electrophoresis buffer (62.5 mM-Tris-HC1 pH 6.8, 2% SDS, 5% 2-mercaptoethanol, 15% glycerol and 0.001% bromophenol blue) by heating at 100 °C for 5 rain.
Immunoprecipitates were analysed by 10~o SDS-PAGE according to Laemmli (1970) and the gels were stained with silver nitrate according to Wray et al. (1981) . For autoradiography, gels were exposed to Kodak X O-mat film with intensifying screens at -70 °C. Mr markers (all products of Sigma) were: phosphorylase<t, Mr 94K; bovine serum albumin, M r 68K; catalase, Mr 57-5K; fumarase, Mr 48.5K, aldolase, Mf 40K.
RESULTS
Neutralization of HCMV infectivity
IgG purified from MAb N2 neutralized HCMV strains AD169 (Table 1) and Davis (Table 1) , but did not affect vervet CMV or herpes simplex virus type 1 infectivity (previously shown by Amad6i et al., 1983) . N2 was shown to exert its effect directly on the virus, since pre-incubation of cells with antibody before virus adsorption did not influence the level of infectivity (results not shown).
Distribution of N2 epitope on cells
By immunofluorescence, N2 detected membrane and internal antigens in uninfected as well as in infected human fibroblasts (Fig. 1) . In addition, this antibody reacted with the cytoplasm and membranes of uninfected human cells of epithelial, muscular ( Fig. 1) and neural (not shown) origin. N2 did not recognize antigens in cells of non-human origin (Fig. 1) .
Immunoprecipitates of uninfected and infected cells were analysed to determine which polypeptide(s) bore the N2 antigenic determinants. N2 IgG precipitated a polypeptide of Mr 94K from uninfected cells (Fig. 2) . After 96 h of infection, N2 also precipitated a polypeptide of Mr 34K from infected cells (Fig. 2) . A mixture of anti-poliovirus IgG did not recognize these polypeptides. When N2 immunoprecipitates of infected cells were analysed under non-reducing t P ~< 0-001 as determined by applying Student's t-test to the difference between the mean number of plaques in the test wells and the mean number of plaques in control wells. P <~ 0.01 (see I"). § P ~< 0.05 (see ~'). conditions (no 2-mercaptoethanol), a polypeptide of Mr 34K, which comigrated with the polypeptide of Mr 34K in reduced samples, was seen at the bottom of the gel (Fig. 3) , suggesting that this polypeptide was not associated with the Mr 94K protein by disulphide bonds.
To investigate the relationship between the 94K and 34K polypeptides, two sorts of pulsechase experiments were performed. In the first, uninfected cells were radiolabelled, chased, then 
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infected and sampled at various times post-infection. Immunoprecipitation of these preparations with MAb N2 showed that the Mr 34K polypeptide was not detectable until 96 h after infection (Fig. 4) . There was a slight decrease in the intensity of the Mr 94K band in cells labelled prior to infection, with a concomitant increase in intensity of the Mr 34K protein. In a second pulse-chase experiment, infected cells were labelled for 10 min, then chased for 20 and 50 min. After 10 min of labelling, only the M~ 94K protein was labelled. As cells were chased the 34K polypeptide also became labelled (Fig. 5) . It is interesting to note that the Mr 94K band appeared as a doublet at the end of the labelling period and after 20 rain of chase. To characterize N2-recognized polypeptides further, uninfected and infected cultures were labelled in parallel with [14C]glucosamine and p SS]methionine to investigate the nature of the N2-recognized proteins. In Fig. 6 it can be seen that the 94K protein appears to be glycosylated but the Mr 34K component does not. N2 did not react with Western blots of uninfected and infected cell proteins (data not shown) under conditions in which other MAbs recognized antigens.
Distribution o f N2 epitopes on fresh isolates of H C M V
To investigate the possibility that the presence of a cellular protein on laboratory strains of HCMV might be related to the number of in vitro passages, the distribution of the N2 epitope was studied on fresh H C M V isolates (Table 2 ) by titrating extracellular virus in the presence and absence of MAb N2. The mean percentage plaque reduction is given for strains that were titrated more than once. The antibody neutralized 66.7~ (18/27) of isolates tested by /> 50~. There was no correlation of either the passage level of isolates or the titre of the isolate in the absence of antibody with the degree of neutralization. Immunoprecipitation with MAb N2 of cells infected with various isolates revealed no differences in the patterns of immunoprecipitation that could provide an explanation for the differences in neutralization. MAb N2 immunoprecipitated an Mr 94K and an Mr 34K band from cells infected by all viruses whether they were neutralized (Fig. 7, lanes 1, 3, 5 , 7 and 9) or not (Fig. 7, lanes 11, 13 and 15 ) by this antibody.
DISCUSSION
The HCMV-neutralizing MAb N2 described in this report reacts with an antigenic determinant situated on a glycoprotein of Mr 94K (gp94) immunoprecipitable from uninfected human fibroblasts. Immunofluorescence demonstrated that this protein was at the membrane and in the cytoplasm (unpublished results) of uninfected cells. It was found on human cells of various origins, but not on cells of non-human origin.
Following infection, a polypeptide of Mr 34K (p34) was also recognized by MAb N2, in addition to gp94. Analysis of immunoprecipitates in the absence of 2-mercaptoethanol indicated that p34 was not linked to gp94 by disulphide bonds. In the short-term pulse-chase experiment (Fig. 4) gp94 was labelled before p34, which suggests that p34 is processed from gp94, although they might be separate proteins bearing the same antigenic determinant. The observation that 
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:-~ 7"-9 P Fig. 4 . Autoradiographsofimmunoprecipitationsofcells labelled for 24 h before infection (lanes I and 2) which were then chased and infected for 18 h (lanes 3 and 4), 48 h (lanes 5 and 6) and 96 h (lanes 7 and 8). For comparison, immunoprecipitates were made from infected cells labelled from 72 to 96 h postinfection (lanes 9 and 10). Each cell extract was precipitated with IgG from MAb N2 (odd-numbered lanes) and anti-poliovirus ascites (even-numbered lanes). M r values are indicated at the side of the gel.
radioactive p34 appeared in infected cells that had been labelled and chased before infection further supports processing of gp94 to yield p34. A gp94 of the AD169 strain has been described as a structural component of H C M V (Sarov & Abady, 1977) . Recently, Kari et al. (1986) described an abundant 93K glycoprotein in one fraction of HPLC-purified, Towne strain glycoproteins. This glycoprotein was not linked to other glycoproteins by disulphide bonds; it was not recognized by their MAbs, which did, however, detect another 93K glycoprotein complex. Determination of whether these two 93K glycoproteins are related awaits peptide mapping. It is possible that one of them corresponds to the 94K glycoprotein described here. A non-glycosylated 34K polypeptide is found in purified virions of all human and simian strains of C MV studied (Britt, 1984; Gibson, 1983; Gupta et al., 1977; Irmiere & Gibson, 1983 Sarov & Abady, 1977; Schmidt et al., 1980; Shuster et al., 1985; Stinski, 1976; Weiner & Gibson, 1981) .
The N2 epitope recognized is most likely discontinuous, as has been described for another HCMV neutralization epitope (Farrar & Greenaway, 1986) . The antibody failed to react with Western blots of purified viral or cellular proteins. So far, immunoprecipitation experiments using purified virus, either dissociated before or after reaction with antibody, have given inconclusive results. Definition of the size of the N2-recognized protein once assembled in the virion will probably require cross-linking to antibody.
The Mr of the N2-recognized polypeptide is close to that of the human transferrin receptor (90K) (Trowbridge & Omary, 1981) . Since expression of this receptor increases upon H C M V infection of fibroblasts (Borysiewicz et al., 1985) , as does expression of N2 membrane antigens, isolates 11, 20 and 38 were not (see Table 2 ). could represent incorporation of a virally modified normal cell component during particle assembly. Envelopment of CMV nucleocapsids was originally thought to occur at the internal nuclear membrane (Smith & de Harven, 1973 ), but recent electron microscopic studies favour acquisition of the final envelope in the Golgi apparatus region of infected cells (Severi et al., 1988) and occasionally at the plasma membrane (Landini et al., 1987) . It is therefore plausible that during envelopment, both virally modified and unmodified normal membrane constituents are incorporated into the viral envelope.
T a b l e 2. Neutralization of fresh isolates and prototype strains of H C M V
The possible existence of a cellular determinant(s) in virus particles could be of significance in the pathogenesis of CMV disease, as discussed by many authors for other viral systems and by Fujinami et al. (1987) and Wiley (1987) for HCMV. Immunological abnormalities of an autoimmune nature are seen to develop and become resolved following the acute phase of CMV infection in patients with no previous history of perfusion. These aberrations include the presence of rheumatoid factor and anti-nuclear (Wager et al., 1968) and anti-smooth muscle (Andersen & Andersen, 1975) antibodies, lymphocytosis, haemolytic anaemia (Zeuler et al., 1966) and thrombocytopenia (Chanarin & Walford, 1973; Fiala et al., 1973; Harris & Meyers, 1975) . A recent report by Revello et al. (1986) showed that primary CMV infection can be diagnosed unambiguously by the appearance of IgM directed against normal cell membrane antigens in the sera of individuals undergoing their first encounter with this agent. It would be interesting to determine which polypeptides of uninfected cells are being recognized by these IgM antibodies.
